Legionella Testing Market Report, Size, Industry Share, Growth, Key Players Analysis, Forecast 2023-2028

The global legionella testing market size reached US$ 285.5 Million in 2022. IMARC Group expects the market to reach US$ 455.6 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.

According to IMARC Group latest report titled” Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a comprehensive analysis of the industry, which comprises insights on legionella testing market trends. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global legionella testing market size reached US$ 285.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 455.6 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.

Legionella testing is a critical process for assessing water systems and facilities for Legionella bacteria, particularly the species responsible for causing Legionnaires' disease, a severe and potentially fatal form of pneumonia. This testing is crucial for healthcare facilities, hotels, cooling towers, and other water systems where Legionella can proliferate. It involves sampling water from various sources, followed by laboratory analysis to identify and quantify Legionella bacteria. Timely and accurate Legionella testing helps prevent outbreaks, ensuring the safety and well-being of occupants and visitors. Regular testing also aids in implementing effective water management strategies to control Legionella growth, ultimately minimizing the risk of infection and safeguarding public health.

Get a Sample Copy of this Report: https://www.imarcgroup.com/legionella-testing-market/requestsample

Market Trends:

The global market is majorly driven by the rising awareness of Legionnaires' disease and its potential to cause severe health issues. Facility owners and operators in the healthcare, hospitality, and industrial sectors recognize the importance of regular testing to protect public health and avoid costly legal liabilities. Furthermore, the stringent regulations and guidelines set by health authorities and occupational safety organizations mandate Legionella testing in specific industries. Compliance with these regulations is crucial, and failure to do so can result in significant penalties and reputational damage, further driving market growth. Moreover, the growing emphasis on water management and hygiene in building systems has bolstered the need for Legionella testing. Facility managers are increasingly adopting comprehensive water management plans that include regular testing to mitigate the risk of Legionella growth in complex water systems. Besides, the advancements in testing methods, such as rapid molecular techniques and automation, have made Legionella testing more efficient and accessible. This has encouraged more facilities to implement routine Legionella testing as part of their risk management strategies. Additionally, the COVID-19 pandemic has heightened the focus on indoor air quality and health and safety in buildings, leading to increased awareness and investment in Legionella testing as part of broader facility hygiene measures.

View Full Report with TOC List of Figure: https://www.imarcgroup.com/legionella-testing-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories Inc
  • Eiken Chemical Co. Ltd
  • Quidel Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc

Legionella Testing Market Segmentation:

Our report has categorized the market based on region, application and end use industry.

Breakup by Application:

  • Water Testing
    • Microbial Culture
    • DFA Stain
    • PCR
    • Others
  • IVD Testing
    • Blood Culture
    • Urine Antigen Test
    • DFA Stain
    • PCR
    • Others

 Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Mark Smith

39 Blog posts

Comments